THE RELATIONSHIPS BETWEEN SERUM COMPLEMENT ACTIVITY AND THE DEVELOPMENT OF ALLERGIC LESIONS IN RABBITS by Rhyne, Marie Britt & Germuth, Frederick G.
THE RELATIONSHIPS BETWEEN SERUM COMPLEMENT 
ACTIVITY AND THE DEVELOPMENT OF 
ALLERGIC LESIONS IN RABBITS* 
BY MARIE  BRITT RHYNE,$ M.D., AND  FREDERICK  G.  GERMUTH, jl~.,§ M.D 
(From the Departments of Pathology, The Johns Hopkins  University School of Medicine, 
Baltimore, and  the  Charlotte Memorial Hospital, Charlotte, North  Carolina) 
(Received for publication, June 16, 1961) 
It has been well established that serum complement levels tend to decrease 
during  experimental anaphylactic  shock  and  serum  sickness  type  hypersen- 
sitivity (1-6). In both anaphylactic shock and experimental "serum sickness" 
there has been a close correlation between the removal of antigen by antibody 
with the formation of complexes and a  fall in the titer of serum complement 
(5-6). The fall in serum complement presumably is due to the  well known ca- 
pacity of antigen-antibody complexes to bind complement. Whether the tissue 
lesions of hypersensitivity are mediated by the activation of complement by 
complexes or  whether  the  binding  of complement is  merely an  unnecessary 
by-product of the antigen-antibody interaction determining the development 
of  the  lesions,  is  unknown. 
The recent experiments of Osler and his coworkers (7-8) implicate comple- 
ment in the mediation of passive cutaneous anaphylaxis. The works of Levine 
(9), Lepow, Ratnoff, and Pillerner (10), and Becket (11,  12)  suggest  that  the 
first component of complement consists of a proesterase which can be activated 
by  antigen-antibody  complexes.  It  is  conceivable that  the  tissue  lesions  of 
hypersensitivity might  be enzymatically induced  through the action of com- 
plement. 
A preliminary study was undertaken to determine the changes in total com- 
plement activity in the serum of animals developing accelerated "serum sick- 
ness."  It  was  found that  a  reduction of total  complement activity in these 
animals  almost always  coincided with  the time of antigen clearance.  Subse- 
quently, attempts were made to lower complement activity in the serum by the 
intravenous  administration  of heterologous immune  precipitates  or  immune 
soluble complexes to determine whether a  reduction in complement activity 
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would  modify  the incidence of allergic lesions in "serum  sickness."  The  accel- 
erated form of serum sickness was employed to lessen the period  of intravenous 
administration of heterologous immune  complexes. 
Materials and Methods 
Experimental Animals.--Male  albino rabbits weighing 2 to 3 kg were used in all experi- 
ments. Alum-precipitated crystallized bovine serum albumin (BSA) was prepared as described 
by Kabat and Mayer (13).  Rabbits were sensitized by 8 dally intravenous injections of 4.2 ml 
alum-precipitated BSA containing 1 mg of protein nitrogen. They were then allowed to rest 
for 3 days after which they were skin-tested with 1 mg BSA protein in 0.2 ml volume. 24 hours 
later skin tests were read and the animals were given a 0.5 gm BSA intravenously for produc- 
tion of accelerated "serum sickness." Most of the animals eliminated the BSA in 3 to 7 days. 
The day of elimination was determined by performing daily antigen capillary tests as described 
previously (14).  Blood samples were taken at appropriate intervals in order to determine the 
level of total complement activity. The animals were usually sacrificed 1 day after the antigen 
became negative at  a  time when the highest incidence of  lesions  would  be expected  (15). 
The tissues were prepared for histologic study in the usual manner. 
Preparation of Bovine Plasma  Gamma Globulin (BGG) Antigen-Antibody Insoluble Com- 
plexes.--BGG  antiserum was obtained from a  large series of rabbits receiving weekly  sub- 
cutaneous injections of 20 mg of this antigen contained in 1 ml Freund's complete adjuvant 
mixture.  At appropriate intervals during immunization, blood was obtained from the mar- 
ginal ear vein and utilized to determine the approximate amount  of circulating antibody. 
Animals with sera containing high concentrations of antibody were bled by cardiac puncture; 
the sera were pooled and stored at -  15°C until used. The average antibody concentration of 
these pooled sera ranged from 0.6 to 0.7 mg antibody nitrogen (AbN) per ml. Immune precipi- 
tates were prepared in antibody excess.  The antigen and antiserum were mixed at room tem- 
perature and allowed to stand at 37  ° for 30 minutes and at 3°C overnight. The resulting pre- 
cipitate was washed once with cold saline, finely dispersed by use of the Waring blender, and 
suspended in isotonic saline so that an aliquot of precipitate containing 20 mg of AbN occupied 
a volume of 50 ml. 
Preparation of Bovine Plasma  Gamma Globulin (BGG) Antigen-Antibody  Soluble Com- 
plexes.--Immune  soluble complexes were prepared by mixing bovine plasma gamma globulin 
and rabbit anti-bovine plasma gamma globulin at equivalence. The mixture was allowed to set 
at room temperature for 10 minutes and then centrifuged for 5 to 10 minutes at 1800 l~P~. 
The precipitate was washed twice with cold physiological saline. To this precipitate was added 
9 X  equivalence of bovine plasma gamma globulin in isotonic saline so that 10 ml of this new 
mixture contained 20 mg ABN.  Even after many hours of shaking precipitates made with 
bovine gamma globulin and its corresponding antibody failed to dissolve in excess antigen. 
Accordingly, this mixture was  treated with sufficient INNaOH  to dissolve the precipitate. 
The resulting pH of this mixture was about 11.5.5 to  10 minutes later, enough INHCI was 
added to adjust the pH to approximately 7.5. The entire procedure  was carried out at room 
temperature. These soluble complexes were prepared just before usage because reprecipitation 
consistently occurred upon standing. 
Titration of Hemolytic Activity of Whole Complement.--Blood was obtained from individual 
rabbits from the marginal ear vein. It was collected in chilled tubes, placed in cold water bath 
at 0°C, and allowed to clot for 4 to 8 hours. The blood was centrifuged at 3°C and the serum 
so obtained was stored at  -60°C.  All blood samples from a  given rabbit were assayed for 
hemolytic activity on the same day.  Hemolytic activity was determined using only slight 
modification of the method described by Kabat and Mayer (13). M. B. RHYNE AND ~'.  G. GERMUTH~ JR.  635 
A sample of rabbit serum obtained from the experimental animals was thawed just before 
determining its hemolytic activity. The temperature of the serum was never allowed to get 
above 3°C. It was again frozen and stored at --60°C after use to allow additional determina- 
tions. The serum was diluted with cold isotonic veronal buffer to yield a concentration suitable 
for estimation of CHs0 units. Preliminary experiments revealed  that the rabbit complement 
hemolysis curve differs from the guinea pig curve in that an end point is not reached even after 
several hours of incubation at 37°C. An incubation time of 3 hours was arbitrarily chosen for 
these experiments.  The percentage of hemolysis was  determined for  each sample and  the 
CH60 units were calculated by the use of the conversion factors derived from the Vou Krogh 
equation with a  value of 0.2 for the exponent  1/n. A complete curve of hemolysis was con- 
structed on occasional sera in order to calculate  1/n experimentally. A value of 0.2 ±  10 per 
cent was found with only occasional deviations. 
Occasional sera with low complement titers were examined for their anti-complementary 
effect. Such sera were heated at 56  ° for 30 minutes, added to active fresh rabbit serum, and 
the hemolytic activity of such mixture was compared with the fresh rabbit serum activity 
alone.  In  no instance was  the heated  serum  anti-complementary. 
Several sera of varying hemolytic activity were examined for the presence of naturally 
occurring hemolysins by using unsensitized sheep cells for the titration of hemolytic activity. 
None of the animals tested was found to have hemolytic antibodies to the sheep red cells em- 
ployed. Several rabbits developing serum sickness type lesions were examined for the pres- 
ence of heterophile antibodies with negative results. 
EXPE]~ rM~.NTAL RESULTS 
I. The Relationship between Serum Complement A trinity, Antigen Elimination, 
and  the  Development  of Allergic  Lesions  in  Accelerated  "Serum  Sickness"  in 
Rabbits.-- 
Forty-three rabbits in five separate experiments were sensitized with alum-precipitated 
BSA and then given 0.  5  gin of BSA for the proeuction of accelerated  "serum sickness." 
The animals were bled on the day of the large injection of antigen and for several days prior to 
this injection. Subsequently, they were bled daily and their sera tested for the presence of 
antigen. The hemolytic complement activity of the serum samples was determined at a later 
date. The results of these determinations are summarized in Table I, where it is apparent that a 
decrease in complement occurred in 42 of 43 animals.  In most instances, this reduction oc- 
curred simultaneously with the complete clearance of antigen by antibody.  This temporal 
relationship  between  antigen  clearance  and  reduction  in  complement  levels  is  presented 
diagrammatically  in  Fig.  1. 
Although there was a very dose time relationship between the drop in com- 
plement and antigen clearance, it is apparent from Table I that the degree of 
complement drop cannot be directly correlated with the presence or absence of 
allergic lesions. 
II.  The Effect  of tke Intravenous Administration of Heterologous Precipitates 
(BGG System)  on Complement  Levels and Incidence  of Lesions in Rabbits  witk 
Accelerated "Serum Sickness."-- 
Preliminary experiments were made to determine the capacity of antigen-antibody pre- 
cipitates to lower hemolytic complement levels. For this purpose, a  series of normal rabbits 
were injected with varying dosages of immune precipitates.  It was found that  a  dosage of 636  ALLERGIC LESIONS 
TABLE I 
Temporal Relationship between Fall in Complement and Antigen Clearance During Accelerated 
"Serum Sickness" 
Rabbit No. 
3-93 
3-83 
3-92 
3-86 
3-91 
70 
9-48 
9-49 
9-55 
9-58 
9-62 
9-68 
9-71 
9-73 
2-46 
2-52 
65 
60 
77 
1-95 
9-54 
9-56 
9-69 
3-89 
62 
68 
72 
78 
79 
80 
64 
69 
2-47 
74 
71 
73 
3-90 
61 
67 
74 
66 
63 
65 
Average CHso 
before large 
dose BSA 
24 
11 
19 
11 
22 
20 
12 
17 
19 
24 
17 
17 
15 
14 
14 
14 
13 
12 
15 
18 
15 
12 
15 
13 
32 
24 
18 
13 
18 
14 
39 
20 
16 
17 
15 
15 
38 
28 
14 
18 
17 
12 
2O 
Lowest CH6o 
after BSA 
12.5 
.6 
1 
0 
9 
5 
1 
7 
0 
7 
3 
4 
5 
3 
6 
6 
4 
7 
6 
2 
4 
1 
8 
16 
15 
7 
10 
8 
1 
12 
8 
9 
8 
8 
6 
8 
1 
7 
4 
9 
10 
10 
13~  ~.~5  ~  n  Day of 
lowest 
CHso 
11.5 
6 
14.4 
10 
12 
11 
7 
16 
12 
14 
10 
14 
11 
9 
11 
8 
7 
8 
8 
12 
13 
8 
14 
5 
16 
9 
11 
3 
10 
13 
27 
12 
7 
9 
7 
9 
30 
27 
7 
14 
8 
2 
10 
4 
4 
4 
4 
4 
4 
4 
3.5 
3 
4 
3.5 
4 
4 
3.5 
4 
4 
3.5 
4 
3 
4 
4 
4 
4.5 
4 
5 
6 
4 
4 
4 
4 
6 
6 
7 
4.5 
7 
6 
6 
9 
9 
7 
9 
9 
13 
Day of 
antigen 
clearance 
3 
3 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4 
4.5 
4.5 
4.5 
4.5 
5 
5 
5 
5 
5 
5 
5 
Presence of allergic 
lesions 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
0 
+ 
Killed day 13 
6 
6 
7 
7 
7 
7 
8 
8 
8 
8 
9 
10 
13 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
0 
+ 
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immune precipitates containing more than 20 mg AbN often produced intravascular  throm- 
bosis and death. The effect of a single intravenous injection of BGG antigen-antibody pre- 
cipitates at a dosage of 20 mg AbN on the hemolytic complement levels of each of 5 normal 
rabbits is shown diagrammatically in Fig. 2. Base line complement levels were determined for 
2 days prior to injection and at  1/~, 2, 4, 8, and 24 hours after injection of the immune pre- 
cipitates. Following the injection of precipitates there was a rapid complement titer drop so 
that at the end of 1~ hour the complement titers ranged from 20 to 40 per cent of their original 
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FIG. 1. Hemolytic complement activity in 2 rabbits developing  accelerated "serum sickness" 
to bovine serum albumin. Complement levels following antigen clearance are represented by 
broken lines. 
value. However, after this time the complement levels began to rise and at 24 hours they were 
60 to 85 per cent of their normal level. Apparently, the intravenous administration of large 
amounts of immune precipitates did not suffice to keep the complement at appreciablp low 
levels for more than a few hours. 
The effect of intravenous injections of precipitated  immune complexes on the total hemo- 
lytic complement levels during accelerated "serum sickness" is shown in Fig. 3. It will be re- 
called that the in vivo antigen-antibody  reaction producing "serum sickness" in itself causes a 
marked  diminution of complement levels. 
It was  found that  the complement levels of  sensitized animals were  further 
reduced by the injection of immune precipitates. As in the normal animals, the 
effects lasted for less than 8 hours. Attempts were made to produce a sustained 
lowering of complement levels by more frequent injections of immune precipi- 
tates.  It was found that  the animals could not withstand treatment by pre- 
cipitates at  the dosage given more frequently than once every 24 hours. 638  ALLERGIC LESIONS 
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TABLE II 
Effect of Daily Intravenous Injections  of Heterologous Precipitates  (BGG System)  on Rabbits 
Devdoping Accderated Serum Sickness  to Bovine Serum  Albumin 
Rabbit No. 
Avg. 
CH~0 
prior  to 
BSA 
Lowest 
observed  Drop 
CHBo  in 
after  CH60 
BSA 
Day of 
lowest 
observed 
CH60 
Day of 
antigen 
clear- 
~,nce 
Lesions 
Arteritis  Glomerulo- 
nephritis 
Animals receiving  immune  precipitates 
9-50 
9-51 
9-52 
9-53 
9-60 
9-61 
9-65 
9-66 
9-67 
9-70 
9-72 
Total No,., 11 
15 
16 
15 
20 
12 
14 
14 
19 
18 
18 
15 
2 
1 
1 
6 
1 
3 
1 
4 
5 
3 
1 
13 
15 
14 
14 
11 
11 
13 
15 
13 
15 
14 
4.5 
4.5 
4.5 
4.5 
3.5 
4 
3.5 
3,5 
3.5 
3.5 
4.5 
4.5 
4.5 
4.5 
4.5 
4 
4 
4 
4.5 
4 
4 
4.5 
-  + 
-  + 
-  + 
+  + 
-  + 
-  + 
+  + 
-  + 
+ 
3 (27 per  9 (82 per 
cent)  cent) 
Animals receiving no immune precipitates 
9-48 
9-49 
1-95 
9-54 
9-55 
9-56 
9-58 
9-62 
9-68 
9-69 
9-71 
9-73 
Total No... 12 
12 
17 
18 
15 
19 
12 
24 
17 
17 
15 
15 
14 
5 
1 
6 
2 
7 
4 
10 
7 
3 
1 
4 
5 
7 
16 
12 
13 
12 
8 
14 
10 
14 
14 
11 
9 
4 
3 
4 
4 
3 
4 
4 
3 
4 
4 
4 
3 
4 
4 
4.5 
4.5 
4 
4.5 
4 
4 
4 
4.5 
4 
4 
+  + 
+ 
+  + 
+  + 
+  + 
+  + 
+  + 
+ 
+  + 
+  + 
+  + 
11  (92 per  9 (75 per 
cent)  cent) 
In  order  to  determine  whether  the  brief  periods  of  reduced  complement 
activity brought about by daily injection of immune precipitates could modify 
the incidence of allergic lesions, a  series of 11  animals were treated with BGG 
immune precipitates beginning 48 hours after the large dose of BSA and con- 
tinuing for 3 days.  12 other animals undergoing accelerated "serum  sickness" 
but  receiving no  treatment  were used  as  controls. M. B. RHYNE  AND F. G. GERMUTH, JR.  641 
Bleedings were performed on all animals just prior to the injection of immune precipitates 
and 8, 12, and 16 hours thereafter. Antigen clearance as well as hemolytic complement titers 
were followed. Each animal was killed 1 day after the antigen had  disappeared from the 
circulation. 
In Table II are recorded, together with the observations on complement titers 
and  antigen  clearance,  the  incidence  of the  two major lesions  (15)  found in 
hypersensitivity of the  serum sickness type.  Since in  the present experiment 
observations were made only at 8,  12, and 16 hours after injection of immune 
precipitates,  the  prompt reduction  in  hemolytic complement titers  following 
BGG precipitates was not  encountered  and no difference in  the  complement 
titers  was observed in  the  two groups of animals. 
Although  the incidence of proliferative glomerulonephritis was found to be 
the same in both the treated and untreated groups, a significant difference was 
observed in the incidence  of arterial lesions between  the control animals and 
those  receiving  BGG  antigen-antibody  precipitates.  Acute  arteritis  was 
observed either  in  the  heart  or lungs  of 92  per  cent  (11/12)  of the  control 
animals and in only 27 per cent (3/11)  of the injected animals. It is of interest 
that the arterial lesions that were present in the treated animals were observed 
only after numerous sections of the heart and lungs were examined and these 
lesions were characterized by slight intimal or adventitia proliferation. Frank 
arterial necrosis which was so common in the control animals was not seen in the 
treated group. 
IlL  The  effect of the  Intravenous  Administration  of tteterologous Soluble 
Immune Complexes (BGG System) on Complement Levels and Incidence of Lesions 
in Rabbits with Accelerated Serum Sickness.--Since it was found impossible to 
give  repeated  frequent  injections  of  immune  precipitates  in  an  attempt  to 
produce  sustained  reduced  levels  of  hemolytic  complement  activity  in  the 
serum,  other  methods  of partial  "decomplementation"  were  sought.  It  was 
found  that  one  could  inject  soluble  immune  complexes  repeatedly  without 
adverse effect on  the  rabbits.  The  effect of soluble  complexes on  hemolytic 
complement level was found to be variable even when prepared under the same 
conditions and in the same degree of antigen excess. At times, the soluble com- 
plexes  were found  to  have no apparent  effect on  complement levels while at 
other  times,  they produced a  noticeable reduction in complement titer  when 
injected  intravenously  into  normal  rabbits.  The  cause  of  this  inconstant 
behavior is not clear but similiar difficulties have been encountered in studies 
on the anaphylactogenic properties of soluble complexes (16,  17). 
In order to study  the effect of heterologous immune complexes on the development of 
allergic lesions and the level of hemolytic complement activity in the serum, 11 rabbits under- 
going accelerated "serum sickness" were injected with 10 ml of BGG immune soluble com- 
plexes (20 nag AbN) at 24 hours after the large dose of BSA.  This treatment was repeated every 
4 hours for the first 24 hours of administration and every 8 hours thereafter until  the animal 
eliminated his BSA antigen.  11 other animals undergoing accelerated serum sickness were 642  ALLERGIC LESIONS 
injected at the same time intervals with 10 ml of a protein solution containing BSA and rabbit 
serum to serve as control animals. This protein solution had been treated with alkali and acid 
in a manner similar to that used in preparation of immune soluble complexes. A third group of 
3 normal animals was injected with immune soluble complexes at the same time intervals as 
TABLE  III 
Effect of Intravenous Injections of Heterologous Soluble Immune Complexes (I0 X  Equivalence) 
(BGG System) on Rabbits De~eloplng  Acederated "Serum Sickness" to Bodne Serum Albumin 
Rabbit No.  p~r 
BSA 
Lowest 
observed 
CH6o 
after 
BSA 
Day of [ 
Drop  [ lowest  [  in  ]  oh-  ] Day of antigen 
CHi0  served  clearance 
CHso 
Lesions 
Arteritis  Glomerulo- 
nephritis 
Animals receiving immune soluble complexes 
12-48  10.5 
12-75  18.1 
12-51  10.2 
12-59  24.0 
12-58 
12-69 
12-52 
12-61 
12-55 
12-62 
12-70 
total No... 11 
6.8 
10.4 
8.5 
11.9 
3.7  3.5 
7.7  5 
1.7  4 
12.1  3.5 
4 
Killed  day  -- 
6, Ag*  +! 
4 
4.5 
3.5 
3 
4.5 
3.5 
4.5  + 
3,5 
3.5 
1 (9 per 
cent) 
+ 
+ 
(trace) 
+ 
+ 
+ 
(trace) 
+ 
+ 
+ 
8 (73 per 
cent) 
12-47 
12-50 
12-53 
12-74 
12-54 
12-64 
12-66 
12-67 
12-72 
12-56 
12-73 
Total No... 11 
Animals receiving control  ~rotein solution 
9.2  6.3  2A 
24.5  14.3  10.~ 
12.6  11.3  1 .~ 
17.5  12.1  5.4 
Killed  day 
6,  Ag  + 
5 
5 
4.5 
4.5 
5 
5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
8 (73 per 
cent) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
7 (64 per 
cent) 
* Ag,  antigen. M'. B. RHYI~ AND Y. G. GERMUTH,  JR.  643 
the experimental animals. 2 of the 3 normal animMs and 4 each of the two groups of sensitized 
animals were bled prior to each injection in order to determine the hemolytic complement 
levels. The sensitized animals were killed 24 hours after the antigen had disappeared from the 
drculation. The normal rabbits were sacrificed with the last sensitized animals. 
In Table IH are recorded the complement levels on these selected sensitized 
animals and observations on antigen clearance and incidence  of the two major 
lesions of "serum sickness" in the two groups of sensitized  animals.  Although 
there was a drop in complement titers in both groups of animals as they devel- 
oped serum sickness, it is apparent that there was no observable difference in the 
complement level between the two groups.  This indicates  that  the injection 
of soluble complexes  had not affected a  reduction in complement levels.  This 
finding  was borne out in the observation that in the normal rabbits treated 
with these same soluble complexes,  the complement levels remained elevated 
despite frequent treatment with the soluble immune complexes. 
Although  the  complement  levels  were unaffected  by the  treatment  with 
soluble  complexes,  apparently,  the  incidence  of  necrotizing  arteritis  was 
markedly reduced in the sensitized animals so treated. The incidence of glo- 
merulonephritis  was the same in the two groups of animals.  It is of interest 
that each of the 3 normal animals receiving multiple injections of soluble com- 
plexes exhibited mild proliferative changes in the glomeruli similar to what has 
been described in Table III as trace glomerulonephritis. 
DISCUSSION 
The present data on hemolytic whole complement titers during serum sick- 
ness hilly support the finding of Janeway and his coworkers indicating a reduc- 
tion in complement titers at the time of development of allergic  lesions.  Cor- 
relation of the time of maximal reduction of complement activity with the time 
of occurrence of complete antigen elimination supports the hypothesis that the 
reduction of complement titer is due to the immune phase of antigen elimina- 
tion.  In only 1 out of 43 animals  was there a  disagreement between antigen 
clearance and the lowest observed complement titer. In view of the numerous 
factors contributing to the supply and demand for complement during "serum 
sickness" it is not Surprising  that the severity of the allergic lesions could not 
be correlated with the magnitude of the reduction in complement activity. 
Although  numerous  attempts  were made by modification of dosage,  time 
intervals, and number of injections to produce a sustained lowering of comple- 
ment titer it was found that the rabbits could not tolerate the large volumes of 
precipitates required to accomplish this state. 
The procedure finally adopted consisted of a single daily injection of finely 
dispersed heterologous immune precipitates. Although this produced a marked 
reduction in complement level, the effect was quite temporary and levels of 
complement activity comparable  to  those  noted  in  untreated  animals  were 644  ALLERGIC LESIONS 
present  during  most  of  the  time  of  the  development  of accelerated  serum 
sickness. 
Although heterologous immune precipitates had little effect on complement 
levels, they profoundly influenced the development of allergic arterial lesions 
in animals developing accelerated serum sickness. It seemed unlikely that the 
failure of the development of necrotizing arteritis was due to the  temporary 
drop in hemolytic complement levels. This belief was supported by subsequent 
work on the effect of heterologous soluble immune complexes on the develop- 
ment of allergic arteritis. Although soluble complexes prepared as herein de- 
scribed failed to produce the slightest observable alteration in total hemolytic 
complement activity, they did effect a marked reduction in the development 
of allergic arteritis. Although these experiments do not clarify the mechanism 
by which allergic arteritis was diminished, they do re-emphasize the extreme 
caution one must employ in correlating the level of whole complement hemolytic 
activity  and  allergic  response. 
The failure of injections of immune soluble or insoluble complexes to influence 
the development of glomerulonephritis while markedly suppressing  the  inci- 
dence of arterial lesions is noteworthy. In view of the focal nature of the arterial 
lesion, one must question whether the marked statistical difference between 
the  incidence  of  arteritis  in  the  treated  and  untreated  animals  was  more 
apparent than real. That this is unlikely was established by the careful examina- 
tion of numerous sections of the heart and lungs of these animals. Furthermore, 
not only was there a difference in the number of animals displaying the lesions 
of arteritis, but there was also such a decided difference in the severity of the 
lesions that did occur that one could easily determine the controls from the 
sensitized animals that had received immune complexes. 
One wonders whether the different effects of the immune complexes on the 
development of the glomerular and arterial lesions is purely a quantitative one 
(18)  or whether this differing effect is  due to fundamental differences in the 
pathogenesis of these two lesions. Although these two lesions are considered to 
have a  common etiological mechanism the possibility exists that they might 
have somewhat different pathologenitic mechanisms. Recent experiments show 
that under certain conditions, each of these lesions can be produced independ- 
ently of one another (18,  19). 
SUMMARY 
Total  serum  hemolytic  complement  activity  is  consistently  reduced  in 
animals undergoing accelerated "serum sickness". The time of maximum reduc- 
tion in complement titer invariably coincides with the time of complete antigen 
disappearance. This temporal relationship supports the belief that the reduc- 
tion  in  complement  titer  is  brought  about  by  in  ~,ivo  antigen-antibody 
combination. M.  B. RHYNE  AND F. G. GERMIJTH, JR.  645 
The  intravenous  administration  of  a  single  daily  large  dose  of  BGG- 
precipitated complexes produces a  marked but temporary reduction in total 
complement  hemolytic activity.  On  the  other  hand,  multiple  injections of 
soluble  BGG  immune  complexes  prepared  in  antigen excess  failed to  even 
temporarily alter complement titers. Animals undergoing the development of 
accelerated "serum sickness" treated by either type immune complex showed a 
significantly reduced incidence of arterial lesions.  Apparently, this inhibiting 
effect on the development of arterial lesions was  independent of variations in 
total  complement  hemolytic  activity. 
The authors gratefully acknowledge  the technical assistance of Herschel McDowell. 
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